Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

The Guardian Friday Nov 20; short piece about antibiotic resistance by a scientist Richard James, who says he was very pessimistic about the the threat of resistance until attending a conference in China about bacteriocins and future antibiotics. By bacteriocin he means bacterial proteins that kill other bacteria, so I am guessing he is referring to peptides like Brilacidin and other HDPs- he uses different words.

Now here we have a drug with a new mode of action ready to enter phase 3.

Now would be the time to see article in the New York Times or NEJM about Brilacidin and its development!
Eventually the story will break, before after during phase 3. I am sure we all expect phase 3 to succeed, but it is a long wait.

Starting to see more about the competition- Oritavancin ads now appearing in various forums(journals, etc) for MDs